ArticleCureus2026
Toxic Epidermal Necrolysis Secondary to Post-surgical Analgesia for Posterior Vaginal Repair.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 26-year-old woman with a history of epilepsy and drug hypersensitivity developed toxic epidermal necrolysis (TEN) following a posterior vaginal repair and levatoroplasty. She experienced fever, general malaise, and rapidly progressing blistering dermatosis, with areas of denuded epidermis and oral mucosal involvement. A dermatological assessment confirmed that her skin involvement exceeded 30%, leading to a clinical diagnosis of TEN. She was transferred to the intensive care unit, where treatment included discontinuation of the suspected drug, intravenous immunoglobulin, systemic corticosteroids, advanced pain management, fluid and electrolyte control, and sterile skin care. The patient showed no signs of sepsis, experienced progressive re-epithelialization, and demonstrated clinical improvement, allowing for discharge with specialized follow-up and strict avoidance of the implicated medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.